Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure
Heart Failure With Preserved Ejection Fraction in the Young
Fluid Volume Overload and Congestion in Heart Failure: Time to Reconsider Pathophysiology and How Volume Is Assessed
Economic and Quality-of-Life Outcomes of Natriuretic Peptide–Guided Therapy for Heart Failure
Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study
Novel percutaneous interventional therapies in heart failure with preserved ejection fraction: an integrative review
SGLT-2 Inhibitors and Cardiovascular Risk: An Analysis of CVD-REAL